enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Cancer Treatment Centers of America - Wikipedia

   en.wikipedia.org/wiki/Cancer_Treatment_Centers...

   On Dec. 29, 2008 CTCA opened Cancer Treatment Centers of America, Phoenix, with a 210,000-square-foot (19,500 m²) hospital serving patients primary from the west coast. On September 18, 2012, Cancer Treatment Centers of America, Atlanta opened to patients. [7] In 2015, it opened a patient concierge and information office in Mexico City. It ...

3. Merck stops testing combo drug for lung cancer - AOL

   www.aol.com/news/merck-stops-testing-combo-drug...

   (Reuters) -Merck said on Thursday it had discontinued a trial testing a combination immunotherapy treatment in patients with a type of lung cancer after an interim analysis showed the drug was ...

4. Merck's Keytruda gets FDA nod for expanded use in lung cancer

   www.aol.com/news/mercks-keytruda-gets-u-fdas...

   The U.S. health regulator's approval extends Keytruda's use in combination with chemotherapy as a treatment given before surgery to shrink the size of the tumor in patients. The U.S. drugmaker is ...

5. Merck scraps two late-stage trials of cancer drug Keytruda

   www.aol.com/news/merck-scraps-two-stage-trials...

   A trial of the drug in patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma was stopped for "futility", meaning it was likely to fail, the company said.

6. Pembrolizumab - Wikipedia

   en.wikipedia.org/wiki/Pembrolizumab

   Micrograph showing a PD-L1 positive non-small cell lung carcinoma. PD-L1 immunostain. As of 2019, pembrolizumab is used via intravenous infusion to treat inoperable or metastatic melanoma, metastatic non-small cell lung cancer (NSCLC) in certain situations, as a first-line treatment for metastatic bladder cancer in patients who cannot receive cisplatin-based chemotherapy and have high levels ...

7. Merck's lung cancer drug combo fails trial in setback ... - AOL

   www.aol.com/news/mercks-lung-cancer-drug-combo...

   Merck's experimental anti-TIGIT drug vibostolimab in combination with its approved therapy Keytruda also failed to improve overall survival in a study of patients with non-small-cell lung cancer ...

8. Merck Gets FDA Nod for Keytruda Lung Cancer Label Expansion - AOL

   www.aol.com/news/merck-gets-fda-nod-keytruda...

   Merck (MRK) gets FDA approval to include overall survival data from a key late-stage lung cancer study, KEYNOTE-189 study, on the label of its PD-L1 inhibitor, Keytruda.

9. Merck's Keytruda Secures First FDA-Approval For Rare Form ...

   www.aol.com/finance/mercks-keytruda-secures...

   The approval marks the first indication for Keytruda in MPM in the U.S. Also Read: Merck/Daiichi Sankyo Partnered Lung Cancer Candidate Meets Primary Goal In Late-Stage Study. MPM is a rare ...